Sarpogrelate

Sarpogrelate is a drug that is classified as a serotonin 2A receptor antagonist. It is primarily used in the treatment of peripheral arterial disease (PAD) and claudication. Sarpogrelate is marketed in Japan and South Korea by Mitsubishi Tanabe Pharma Corporation under the brand name Anplag.

Mechanism of Action[edit | edit source]

Sarpogrelate works by inhibiting the action of serotonin on its 2A receptor. This results in a decrease in platelet aggregation, which can help to prevent the formation of blood clots. It also has a vasodilatory effect, which can help to improve blood flow in patients with peripheral arterial disease.

Uses[edit | edit source]

Sarpogrelate is used in the treatment of peripheral arterial disease and claudication. It can help to improve symptoms such as pain and cramping in the legs that are caused by reduced blood flow.

Side Effects[edit | edit source]

Common side effects of sarpogrelate include nausea, vomiting, diarrhea, and abdominal pain. In rare cases, it can cause serious side effects such as bleeding, thrombocytopenia, and leukopenia.

Contraindications[edit | edit source]

Sarpogrelate is contraindicated in patients with a history of hypersensitivity to the drug or any of its components. It is also contraindicated in patients with severe liver disease or kidney disease.

See Also[edit | edit source]

Sarpogrelate Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.